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Abstract  
Introduction 
Proper control of blood pressure reduces the risk of developing cardiovascular and cerebrovascular 
complications in hypertensive people. However, this control remains mostly unsatisfactory. 
Although alexithymia has been associated with essential hypertension, no study has analysed the 
relationship between alexithymia and blood pressure control in drug-treated hypertension. 
This research aimed to analyse the presence and the characteristics of this relationship, considering 
both the pharmacological treatment and the achievement of adequate maintenance of blood pressure 
in a physiological range. 
Method 
One thousand two hundred and forty-one people participated in the study. Eight hundred and ten 
were hypertensive patients, and four hundred and thirty-one were normotensive people. The 
Toronto Alexithymia Scale-20 was used to assess alexithymia.  
Results 
Results show that hypertensive people are more alexithymic than normotensive people. According 
to the presence of pharmacological treatment, treated hypertensive patients are more alexithymic 
than normotensive and not treated hypertensive patients. Considering the blood pressure control 
associated with the drug-therapy, people with uncontrolled hypertension are more alexithymic than 
normotensive and untreated hypertensive people.  
Conclusions 
These findings confirm a relationship between alexithymia and essential arterial hypertension, but 
they also highlight that alexithymia appears to be associated with higher severity of hypertension. 
Alexithymia could be a facet of uncontrolled hypertension. 
 
Keywords: Essential Hypertension, Alexithymia, Drug Treatment of Hypertension, Uncontrolled 
Hypertension 
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1. Introduction 
High blood pressure (or hypertension) is a global public health problem, and it represents the 
indirect cause of 7.5 million of deaths (12.8% of total deaths) (World Health Organization, WHO, 
2013). Hypertension is correlated independently and linearly with an increased risk of developing 
cardiovascular and cerebrovascular complications (Britton, Gazziano, & Djoussé, 2009; Iadecola & 
Davisson, 2008; Lewington et al., 2003; Meissner, 2016). Some studies have evidenced a 
progressive and linear increase of cardiovascular disease for each rise of 20/10 mmHg of blood 
pressure, starting from the value of 115/75 mmHg (Lewington et al., 2003). 
Proper control of blood pressure reduces the risk of developing heart and cerebrovascular diseases 
(Go et al., 2014). Conversely, insufficient control of blood pressure contributes to increased risk of 
developing myocardial infarction, cerebral stroke, heart failure and other diseases (Bramlage et al., 
2010; Chobanian, 2009; Prugger et al., 2011).   
Essential hypertension has a multifactorial aetiology, and many studies have highlighted the 
influence of psychological factors both in the general increase of blood pressure and in the possible 
development and maintenance of hypertension. Specifically, the role of anger (Shehata, 2010), 
anxiety and depression (Rafanelli, Offidani, Gostoli, & Roncuzzi, 2012; Rubio-Guerra et al., 2013), 
acute stress (e.g., traumatic life events), negative emotions (Spruil, 2010) and type D personality 
(Grande, Romppel, & Barth, 2012) are well known. 
Among the psychological dimensions investigated in connection to hypertension, there is also 
alexithymia (Grabe et al., 2010; Jula, Salminen, & Saarijarvi, 1999; Todarello, Taylor, Parker, & 
Fanelli, 1995). 
Alexithymia is a multidimensional and transdiagnostic construct characterised by difficulties in 
identifying and describing feelings, in distinguishing between feelings and bodily sensation of 
emotional arousal, and by an external oriented style of thinking (Taylor, Bagby, & Parker, 1997).  
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The prevalence of alexithymia ranges between 7.1% (Joukamaa et al., 2003), 10% (Franz et al., 
2008) and 12.8% (Salminen et al., 1999) in the general population. High levels of alexithymia have 
been highlighted in different psychological disorders, such as depression (Li, Zhang, Guo, & 
Zhang, 2015), anxiety (Frewen, Dozois, Neufeld, & Lanius, 2008), somatoform disorders (Melin, 
Thuleius, & Persson, 2010), substance addiction (Coriale et al., 2012), eating disorders (Miyake et 
al., 2012), abuse of alcohol and drugs (Helmers & Mente, 1999) and incorrect eating habits 
(Casagrande, Boncompagni, Forte, Guarino & Favieri, 2019). Alexithymia was also considered a 
risk factor for cardiovascular mortality (Tolmunen et al., 2010), and it is associated with low drug 
therapy adherence (Axelsson et al., 2009).  
Many studies have highlighted an association between hypertension and alexithymia; some authors 
have reported a more significant association (Jula et al., 1999; Todarello et al., 1995); while others 
have shown less robust effects (Chachaj et al., 2009; Hanninen et al., 2011) and others have not 
confirmed this relationship (Linden, Lenz, & Stossel, 1996; McCubbin et al., 2013). However, the 
nature of this association and how much alexithymia is linked to the severity of hypertension are 
not clear (Gage & Egan, 1984). To our knowledge, no study has analysed the relationship between 
alexithymia and blood pressure control in hypertension, considering drug therapy. 
This study aims to examine the association between hypertension, alexithymia and blood pressure 
control in a sample of Italian adults not affected by other medical or psychological diseases.  
For these aims, three different subsections with different objectives have been planned: 
1. To confirm the association between hypertension and alexithymia as reported in other studies 
(Jula et al., 1999; Todarello et al., 1995) (subsection 1); 
2. To investigate whether the presence or absence of antihypertensive pharmacological treatment is 
differently related to alexithymia  (subsection 2);  
3. To examine the association between alexithymia and uncontrolled hypertension, in treated 
hypertensive patients (subsection 3), specifically to understand whether the lack of control of blood 
pressure can be associated with higher levels of alexithymia.  
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In general, we expect that alexithymic characteristics are associated with hypertension, particularly 
considering severe hypertension conditions, such as the uncontrolled condition.  
2. Method 
2.1. Participants 
One thousand two hundred and forty-one people participated in the study; they were recruited at the 
First Medical Clinic of the Policlinico Umberto I of the University of Rome "Sapienza" between 
2014 and 2017. Hypertensive patients were selected at the Hypertension Centre, and the control 
group was recruited from the Geriatric dental surgery, within the same Medical Clinic. A 
cardiologist provided information on drug treatment (number of drugs assumed).  
In accordance with European guidelines for the diagnosis and treatment of arterial hypertension 
(Mancia et al., 2013; Williams et al., 2018), the participants were divided into two groups: 
hypertensive (N= 810 [376 Male, 434 Female]; Age= 60.08 years; SD= 11.15) who had a 
Systolic/Diastolic  blood pressure equal to or higher than 140/90 mmHg or were under drug 
treatment for hypertension; normotensive (N= 431 [158 Male, 273 Female]; Age= 51.54 years; SD= 
10.17) who presented Systolic/Diastolic  blood pressure values lower than 140/90 mmHg 
(subsection 1). 
Subsequently (subsection 2), hypertensive patients were subdivided, considering drug therapy, into 
two subgroups: Hypertensive patients under drug treatment (N= 545; [255 Male, 290 Female]; 
Age= 62.28; SD= 10.88) and Untreated Hypertensive patients (N= 265 [121 Male, 144 Female]; 
Age= 55.55; SD= 10.33). Finally (subsection 3), the participants who were classified under 
pharmacological treatment were further subdivided into: patients with Controlled Hypertension 
(those who presented a blood pressure lower than 140/90 mmHg) (N= 209; Age= 62.00; SD= 
10.81), and patients with Uncontrolled Hypertension (N= 336; Age= 62.46; SD= 10.93) if they had 
a Systolic/Diastolic blood pressure equal to or higher than 140/90 mmHg.  
Inclusion criteria were: aged over 40 years, being native Italian speakers and, only for the 
hypertensive patients, receiving a diagnosis of essential hypertension by a cardiologist. Participants 
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who presented chronic conditions such as cancer, diabetes, cardiac or neurological and psychiatric 
disorders were excluded from the study. Participants were also not included in the research when 
they present a Systolic/Diastolic blood pressure equal or higher than 140/90 mmHg and they were 
taking a drug therapy consisting of at least three classes of drugs, one of which was represented by a 
diuretic, since this typology of hypertensive patients is considered drug-resistant (Sheppard, Martin, 
& McManus, 2017).  
Figure 1 reports the exclusion criteria of participants. 
2.2. Assessment tools 
2.2.1. Physiological measures 
Systolic (SBP) and Diastolic blood pressure (DBP) and Heart Rate were recorded by using an 
automatic electronic sphygmomanometer validated for self-measurement ("Personal Check" PIC) 
(Germanò et al., 2010). 
Blood pressure measurement was performed according to the European guidelines criteria (Mancia 
et al., 2013). Blood pressure has been categorized as optimal (SBP lower than 120 mmHg  and DBP 
lower than 80 mmHg), normal (SBP equal to 120-129 mmHg and DBP lower than 85 mmHg), high 
normal (SBP equal to 130-139 mmHg or DBP equal to 85-89 mmHg), grade I hypertension (SBP 
equal to 140-159 mmHg or DBP equal to 90-99 mmHg), grade II hypertension (SBP equal to 160-
179 mmHg or DBP equal to 100-109 mmHg) and grade III hypertension (SBP equal to or higher 
than 180 mmHg or DBP equal to or higher than 110 mmHg).  
After a 5-minute rest in which participants were seated on a comfortable chair with their backs 
resting on their backrests, they were required to keep silent, and consequently, the three 
recommended measurements were carried out on the non-dominant arm, at about 2 minutes from 
each other. 
For subsequent analyses, the mean value of both SBP and DBP was considered. Furthermore, the 
Mean Arterial Pressure (MAP) was computed; this is defined as the mean blood pressure in a 
patient’s arteries during one cardiac cycle. It is considered an indicator of perfusion to vital organs 
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and it can be estimated by using the formula: MAP= [SBP + 2(DBP)]/3. Finally, Heart Rate (HR) 
was also recorded. 
A balance and a meter were used to measure the weight and height of the participants. Weight and 
height were used to calculate the Body Mass Index (BMI), an indirect estimate of the individual’s 
body fatness. BMI was obtained by dividing weight (in kilograms) by height (in metres squared) 
(NCD Risk Factor Collaboration, 2016). 
2.2.2. Socio-demographic and anamnestic information 
Demographic data (age, gender, marital status, years of education), lifestyles (smoking, alcohol 
consumption), medical and psychiatric information were collected for each patient by face-to-face 
interview. A questionnaire on compliance with the pharmacological treatment (3-point Likert scale) 
was included in the interview in the first part of the research (2014-2015), subsequently (2016-
2017) this was replaced by a short questionnaire composed of four items with a dichotomous 
answer (yes/no), with the aim to investigate adequate adherence to drug therapy.  
2.2.3. 20-item Toronto Alexithymia Scale (TAS-20) 
TAS-20 (Bagby, Parker, Taylor, 1994; Italian validation: Bressi et al., 1996) is a self-report 
questionnaire that allows evaluating alexithymia. It includes 20 items on a 5-point Likert scale (1= 
strongly disagree, 5= strongly agree). The test also permits assessing the three different facets of 
alexithymia: Difficulty Identifying Feelings (DIF); Difficulty Describing Feelings (DDF); 
Externally Oriented Thinking (EOT). The scores range from 20 to 100 and proved both categorical 
and continuous information. In categorical classification, three different levels of alexithymia are 
considered: non-alexithymic (scores below 51); moderately alexithymic (scores between 51 and 
60); alexithymic (scores above 60). 
2.3. Procedure 
The research was conducted according to the Declaration of Helsinki and approved by the Local 
Ethics Committee. Following the signing of the informed consent, the participants were subjected to 
blood pressure recordings; after this recording, weight and height were measured. Then, the 
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participants were submitted to the socio-demographic and anamnestic interview, and they 
completed the TAS-20. After this procedure, hypertensive patients were visited by a cardiologist, 
who carried out the diagnosis. The whole procedure, lasting 40 minutes, took place in a quiet 
environment with a comfortable temperature.  
2.4. Statistical analysis 
Raw scores of the two adherence scales were transformed into z scores. 
To assess the presence of differences between groups, one-way analyses of variance (ANOVAs) 
were carried out considering the Group as the independent variable and the adherence to drug 
treatment, the average number of drugs taken, the different socio-demographic and physiological 
dimensions, and the lifestyles as dependent variables. If significant differences were found for more 
influential variables (age, gender, years of education and BMI), these were included in the 
covariance analyses (ANCOVAs) for the analyses of alexithymia, considering as outcomes the total 
score on the TAS-20 and its subscales (Difficulty Identifying Feelings, Difficulty Describing 
Feelings, Externally-Oriented Thinking). Moreover, to compare the percentage of alexithymic and 
non-alexithymic individuals in the different groups, the χ2 test was used 
In the subsections with more than two groups, the differences between groups were tested with 
planned comparisons that contrasted the means between the three (subsection 2: normotensive, 
untreated hypertensive, treated hypertensive) and four (subsection 3: normotensive, untreated 
hypertensive, controlled hypertensive and uncontrolled hypertensive) groups.  
Using G-Power software (Faul et al., 2009), a sensitivity analysis was carried out to compute the 
effect size associated with a power equal to 0.80 according to the sample size of the study. The 
expected effect sizes expressed in partial eta squared were of 0.005 (subsection 1), 0.006 
(subsection 2), 0.008 (subsection 3).  
For all the statistical analyses, the level of significance was accepted at p< 0.05.  
To reduce the risk of a Type 1 error, a Bonferroni’s correction was applied in the subgroups 
analysis. A p<  0.02 was accepted in the second and third subsections. 
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Statistical analyses were performed through the Statistica Software v.10.0. 
3. Results 
The global sample has been differently separated according to the different types of analyses 
suitable to answer the research questions. The results have been reported in different subsections, 
each addressing one type of analysis. Table 1 shows the descriptive statistics.  
3.1. Subsection one: Assessment of the association between hypertension and alexithymia  
Table 2 shows the differences between groups in demographics (age, gender, years of education, 
BMI), lifestyles and physiological variables. 
Alexithymia 
The χ2 test shows a different Alexithymic/Non-Alexithymic ratio in the two groups (χ2 = 10.6; p< 
0.002). Specifically, there was a higher percentage of alexithymic people in the hypertensive group 
compared to the normotensive group (16.4%. 11.4%). 
ANOVAs performed on the TAS-20 scores showed a significant difference between the groups in 
the overall score of Alexithymia (F1,1239= 28.76; p< 0.0001; pƞ
2
= 0.02), the Difficulty Identifying 
Feelings (F1,1239= 19.68; p< 0.0001 pƞ
2
= 0.01), the Difficulty Describing Feelings (F1,1239= 11.77; 
p< 0.001; pƞ2= 0.01) and  the Externally Oriented Thinking (F1,1239=16.50; p< 0.0001; pƞ
2
= 0.01). 
Since age, years of education and BMI were significantly different between groups, they were 
introduced as covariates in the analyses. 
ANCOVAs performed on the TAS-20 scores confirmed significant differences between groups in 
both the overall score of Alexithymia (49.01 vs. 45.08; F1,1235= 3.92; p= 0.05; pƞ
2
= 0.003) and the 
Difficulty Identifying Feelings (16.28 vs. 14.47; F1,1235= 5.40; p= 0.02 pƞ
2
= 0.004). Conversely, 
Difficulty Describing Feelings (F1,1235= 1.06; p= 0.30) and Externally Oriented Thinking (F1,1235< 1; 
p= 0.46) were no longer significantly different (see Table 2).  
3.2. Subsection two: Assessing alexithymia in people with untreated hypertension and under 
drug treatment hypertension  
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Table 3 shows the differences between groups in demographics (age, gender, years of education, 
BMI), lifestyle and physiological variables. 
Alexithymia 
The χ2 test showed a higher presence of alexithymic individuals in the treated hypertensive group 
compared to both the normotensive group (χ2= 16.21; p< 0.001; 18.5% vs. 11.4%) and the untreated 
hypertensive group (χ2= 8.08; p< 0.01; 18.5% vs. 12.1%), while there were no significant 
differences in the number of alexithymic people between normotensive and untreated hypertensive 
groups (χ2< 1; p= 0.59).  
ANOVAs performed on the TAS-20 scores showed a significant difference between the groups in 
the overall score of Alexithymia (F1,1238= 22.77; p< 0.0001; pƞ
2
= 0.03), the Difficulty Identifying 
Feelings (F1,1238= 13.29; p< 0.0001 pƞ
2
= 0.02), the  Difficulty Describing Feelings (F1,1238= 8.28; p< 
0.001; pƞ2= 0.01) and  the Externally Oriented Thinking (F1,1238=17.96; p< 0.0001; pƞ
2
= 0.03). 
Since age, years of education and BMI were significantly different between groups, they were 
introduced as covariates in the analysis considering alexithymia. 
The ANCOVAs on the TAS-20 scores showed significant differences between the groups in 
Difficulty Identifying Feelings (F2,1234= 3.31; p= 0.04; pƞ
2
= 0.01) with higher scores in the treated 
hypertensive group than the normotensive group (F1,1234= 6.61; p= 0.001; pƞ
2
= 0.01); a significant 
difference was also confirmed for Externally Oriented Thought (F2,1234= 3.89; p= 0.02; pƞ
2
= 0.01) 
with higher scores in the treated hypertensive group than both the untreated hypertensive (F1,1234= 
7.25; p= 0.007; pƞ
2
= 0.01) and the normotensive (F1,1234= 3.54; p= 0.06; pƞ
2
= 0.003) groups. 
Difficulty Describing Feelings did not show significant differences (F< 1; p= 0.48). Finally, the 
TAS-20 total score was different between groups (F2,1234= 3.88; p= 0.02; pƞ
2
= 0.01), the treated 
hypertensive group had higher scores than both normotensive (F1,1234= 7.05; p= 0.008; pƞ
2
= 0.01) 
and untreated hypertensive (F1,1234= 3.84; p= 0.05; pƞ
2
= 0.003) groups (Figure 2). Considering the 
Bonferroni’s correction, there were not substantial changes in the results. 
3.3. Subsection three: Assessing alexithymia in people with uncontrolled hypertension 
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
11 
 
Table 4 shows the differences between groups in demographics age, gender, years of education, 
BMI, lifestyles and physiological variables. 
Adherence 
The ANCOVA performed on the adherence of the two pharmacologically treated groups 
(uncontrolled hypertensive and controlled hypertensive) did not show significant differences 
(F1,539= 2.56; p= 0.11), although the average scores of adherence were marginally higher in 
controlled hypertensive individuals (see Table 2). 
An ANOVA conducted considering the classification of alexithymia as the independent variable 
(alexithymic, non-alexithymic, moderately alexithymic) and adherence to pharmacological 
treatment as the dependent variable showed no significant differences (F 2,539= 1.92; p= 0.15); the 
correlational analysis between TAS-20 scores and adherence scores did not show any relations 
between these variables (r= -0.06; p= 0.16). 
Alexithymia 
The X
2
 analysis showed a higher percentage of alexithymic people in the controlled hypertensive 
group than both untreated hypertensive (X
2
= 7.17; p< 0.01; 20.1% vs. 12.1%) and normotensive 
(X
2
= 12.71; p< 0.001; 20.1% vs. 11.4%) groups, but not compared to the uncontrolled hypertensive 
group (X
2
< 1; p= 0.64; 20.1 vs. 17.6). The latter group show significant differences compared to 
both untreated hypertensive (X
2
= 5.96 p= 0.01; 17.6% vs. 12.1%) and normotensive (X
2
= 11.62; p< 
0.001; 17.6% vs. 11.4%). 
ANOVAs performed on the TAS-20 scores showed a significant difference between the groups in 
the overall score of Alexithymia (F1,1237= 15.49; p< 0.0001; pƞ
2
= 0.04), the Difficulty Identifying 
Feelings (F1,1237= 9.61; p< 0.0001 pƞ
2
= 0.02), the Difficulty Describing Feelings (F1,1237= 5.52; p< 
0.001; pƞ2= 0.01) and  the Externally Oriented Thinking (F1,1237=11.98; p< 0.0001; pƞ
2
= 0.03). 
Since age, years of education and BMI were significantly different between groups, they were 
introduced as covariates in the analysis considering alexithymia. 
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The ANCOVAs on the TAS-20 scores showed significant differences in both Difficulty Identifying 
Feelings (F3,1233= 2.56; p= 0.05; pƞ
2
= 0.01) and Externally Oriented Thought (F3,1233= 2.63; p= 
0.05; pƞ2= 0.01), while no significant differences were evident in the Difficulty Describing Feelings 
(F< 1; p= 0.68). 
Regarding the Difficulty Identifying Feelings, the uncontrolled hypertensive group presents higher 
scores than the normotensive group (F1,1233= 7.67; p= 0.006; pƞ
2
= 0.01); concerning Externally 
Oriented Thought, the uncontrolled hypertensive group differs from untreated hypertensive (F1,1233= 
6.74; p= 0.009; pƞ2= 0.01) and normotensive (F1,1233= 3.38; p= 0.06; pƞ
2
= 0.003) groups (see Figure 
3).  
The TAS-20 total score showed a significant difference (F3,1233= 2.81; p= 0.03; pƞ
2
= 0.01), in this 
case the uncontrolled hypertensive differed from normotensive (F1,1233= 7.57; p= 0.006; pƞ
2
= 0.01) 
and untreated hypertensive groups  (F1,1233= 4.51; p= 0.03; pƞ
2
= 0.004), but not from controlled 
hypertensive (F< 1; p= 0.41) group (see Figure 3). Considering the Bonferroni’s correction, there 
were no substantial changes in the results. 
4. Discussion 
The transdiagnostic construct of alexithymia has often been associated with both personality 
(Grande et al., 2012) and mood characteristics (Rafanelli et al., 2012; Rubio-Guerra et al., 2013). 
Moreover, alexithymia has often been associated with dysfunctional physiological aspects, leading 
to medical diseases (Asi Karakas et al., 2016; Panayiotou, 2018). 
Many studies have highlighted a strong association between alexithymia and hypertension 
(Hanninen et al., 2011; Chachaj et al., 2009; Grabe et al., 2010; Jula et al., 1999; Niiranen et al., 
2006; Todarello et al., 1995). However, to our knowledge, there are no studies that investigated 
alexithymia referring to all aspects of essential hypertension and, specifically, no study has 
investigated pharmacological treatment or have compared patients under drug treatment with 
untreated patients. 
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For these reasons, the primary aim of this study was to investigate the link between alexithymia and 
hypertension, considering drug treatment. This goal has been pursued through a step-by-step 
approach aimed to highlight the actual weakness of information, too generic, on this topic and to 
focus on different aspects of hypertension gradually.  
The first subsection confirms well-known findings (i.e., Jula et al., 1999; Todarello et al., 1995). 
There is a higher presence of alexithymia in individuals with essential hypertension compared with 
normotensive people. Our findings confirmed this association, also controlling the results for BMI, 
years of education, gender and age and excluding people with other medical and psychological 
diseases.  
The overall percentages of Hypertension (65%) and Alexithymia (15%) highlighted in this study are 
in line with those found in the general population (Franz et al., 2008; Tocci et al., 2015). However, 
the percentage of alexithymic persons in the group of hypertensive patients is much lower than that 
reported by other authors (Jula et al., 1999; Todarello et al., 1995) that found a percentage higher 
than 50%. In our study, the percentage found is significantly lower (16.4%). These differences may 
depend on some methodological aspects. For example, despite the well-known relationships of age 
with both alexithymia (Salminen et al., 1999) and blood pressure (Lewington, 2002), age was not 
considered in the data analysis of other studies. Moreover, in Todarello et al.’s study (1995), 
hypertensive patients were older compared to the other groups (mean age of hypertensive patients= 
52.5 years; psychiatric patients: 39.0 years; control subjects: 40.8 years). On the other hand, Jula 
and co-workers (1999) assessed alexithymia using the TAS-26 (Taylor, Ryan, & Bagby, 1985; 
Taylor et al., 1988) that presents some psychometric limitations compared to the TAS-20 (Bagby et 
al., 1994).  
Nevertheless, our findings confirm the presence of higher emotional dysregulation in hypertensive 
patients. Hypertensive people show more difficulty in identifying feelings and distinguishing them 
from somatic sensations. So, these primary analyses suggested that alexithymia could be considered 
an additional and general risk factor for essential hypertension, as expressed in previous literature 
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(Grabe et al., 2009), although it must be emphasised that the present study only highlights an 
association between alexithymia and hypertension and does not allow establishing a causal 
relationship. 
The second subsection focused on a classification that considered pharmacological treatment. This 
aspect has a significant impact on the quality of life (Lauziére et al., 2013; Schmidt, Bramlage, 
Limberg, & Kreutz, 2008; Souza, Borges, & Moreira, 2016) and it is usually associated with higher 
severity of hypertension (Whelton et al., 2017).  
In most cases, hypertension does not present manifest symptomatology. For this reason, 
hypertension is known as the "silent killer", and it is estimated that in the general population there is 
a variable percentage of hypertensive individuals who do not know their condition and, 
consequently, they do not receive any treatment to control their blood pressure (Tocci et al., 2015). 
Untreated hypertensive people would seem to present emotional dysregulation (Jula et al., 1999). 
However, no studies have considered alexithymia in people with drug-treated hypertension.  
In general, our results highlighted a percentage of 32.71% untreated hypertensive participants. This 
percentage is in line with a previous Italian study (Tocci et al., 2015). Untreated hypertension is a 
significant risk factor for the development of cardiovascular disorders due to its association with 
higher risk behaviours (Whelton et al., 2017). Our findings confirm this hypothesis. Untreated 
hypertensive patients show more problematic dimensions as indicated by both physiological (blood 
pressure indices) and lifestyles (alcohol and cigarette smoking) (Niiranen et al., 2006; Virdis et al., 
2010; Whelton et al., 2017). Moreover, they are younger than treated hypertensive patients; this 
result could be due to the absence of the hypertensive symptomatology; in fact, hypertension is 
often silent, and consequently, blood pressure control is rarely performed at a younger age (Sawicka 
et al., 2011). 
However, this physiological and behavioural trend would seem to be dissociated from the tendency 
of emotional dysregulation, as expressed by a higher percentage of alexithymic in treated 
hypertensive groups (18.5%). 
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The results showed that among the populations considered, hypertensive patients under 
pharmacological treatment present higher alexithymic characteristics than the other groups. They 
appear more unable to distinguish their feelings from somatic sensations and show a restricted 
imaginative process characterised by outwardly directed cognitive style (Taylor et al., 1999). 
These findings provided us further information compared to that observed in the previous studies; 
alexithymia, independently from other factors, such as BMI, age, gender and years of education, 
appears to be associated more closely with drugs treated hypertension, i.e. more severe 
hypertension. These results allow a higher knowledge on this topic. 
Therefore, our findings seem to highlight that emotional dysregulation is not associated by itself 
with higher blood pressure, as evidenced by previous studies (e.g., Todarello et al., 1995), but rather 
by more severe hypertension requiring pharmacological treatment. 
The last subsection was aimed to clarify the role of alexithymia in maintaining optimal blood 
pressure control during pharmacological therapy, which is essential to minimise cardiovascular 
risks (Flack et al., 2018; Go et al., 2014). It is well known that some people present failure to 
control blood pressure; this condition is called uncontrolled hypertension (Sheppard et al., 2017). It 
is associated with patients’ reduced compliance, incorrect lifestyles, inadequate drug therapy or real 
drug resistance (Jankowska-Polanska et al., 2017; Whelton et al., 2017).  
Previous studies have investigated some psychological dimensions connected to the lack of control 
of blood pressure (Sanz et al., 2010); no study had ever investigated the relationship between 
uncontrolled hypertension and alexithymia. Furthermore, no study has ever considered a 
classification of hypertension under pharmacological treatment into two further divisions linked to 
the effectiveness of drug therapy. This distinction allowed us to highlight how the group with 
uncontrolled hypertension presented both a higher percentage of alexithymic and moderately 
alexithymic people and higher scores on the TAS-20 than the normotensive and untreated groups. 
The results show more difficulty in identifying feelings and more external oriented thought in the 
uncontrolled hypertensive group than the other groups. 
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On the one hand, this result confirms the hypothesis that the lack of blood pressure control is 
associated with some psychological characteristics of patients such as personality traits (Sanz et al., 
2010) and coping strategies (Casagrande et al., 2019), on the other hand, it also highlights a 
relationship between alexithymia and higher severity of hypertension. 
It is relevant to underline that in our sample uncontrolled hypertensive people do not show poor 
therapeutic adherence, even if they present unhealthier behaviours (Niiranen et al., 2006; Virdis et 
al., 2010; Whelton et al., 2017). Moreover, these results were obtained by controlling the variables 
most associated with both alexithymia and hypertension (age, BMI, years of education and gender).  
In our opinion, the strength of this study is (a) the methodological organisation that has allowed 
focusing and analysing the various dimensions linked to hypertension, (b) to have controlled some 
variables, i.e. BMI, age, gender and years of education, commonly associated with both 
hypertension and alexithymia. BMI is positively associated with both a significant emotional 
dysregulation (Casagrande et al., 2019; Waldstein et al., 2002) and higher blood pressure levels 
(Brown et al., 2000; Shihab et al., 2002). Moreover, older age represents a known risk factor for 
hypertension (Sun, 2015), and it is positively associated with alexithymia (Mattila, Salminen, 
Nummi, & Joukamaa, 2006). Also, years of education seem to be associated with both hypertension 
(Chobanian et al., 2003) and alexithymia (Lane, Sechrest, & Riedel, 1998; Pasini, Delle Chiaie, 
Seripa, & Ciani, 1992; Salminen et al., 1999) indicating that there is an increased risk associated 
with a low education in both cases. Considering gender (for a review see Levant, Hall, Williams, & 
Hasan, 2009), some studies have reported a difference in the levels of alexithymia between males 
and females, with a higher percentage of alexithymia in the male population (Lane, Sechrest , & 
Riedel, 1998), while others, in line with our results, do not report significant differences (Pasini et 
al., 2002). 
In the present study, analyses were carried out without and with the introduction of covariates (age, 
BMI, years of education). In the first case, the results were significant in all the subscales of TAS-
20. After the adjustment for confounding variables, Difficulty Describing Feelings no longer 
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discriminates between groups, therefore this aspect of emotional regulation is strongly influenced 
by the modulating variables considered.  
Another point of strength of this study is to have used rigorous inclusion criteria for excluding 
participants that presented important medical and psychological diseases, an aspect often not 
controlled by other studies (e.g., Todarello et al., 1995). 
Moreover, the results of this study appear to be robust, considering that the effect sizes were similar 
to that expected in the sensitivity analysis. 
Assuming that uncontrolled hypertension is to be placed at the most severe point of the 
hypertensive continuum (Iyer et al., 2010; Zhou et al., 2018), this study would seem to show that 
alexithymia represents a factor that should be considered in hypertensive patients, especially for 
severe hypertension. These results could depend on the association of alexithymia with poor 
therapeutic adherence (Lumley, Neely, & Burger, 2007); however, in our study, this association is 
not present. The physiological activations associated with emotions (e.g. increase in blood pressure, 
HR, body temperature, skin conductance) may mediate the role between hypertension and 
alexithymia. Alexithymic people, who experience but do not consciously process their emotions, 
could undergo an increase in the physiological activation resulting from an emotional event 
(Neumann et al., 2004). In the long run, this could affect the physiological self-regulation and be 
consequently associated with a higher autonomic activation leading to more elevated blood 
pressure, but our empirical evidence cannot confirm this hypothesis. To appropriately consider the 
relationship between alexithymia and autonomous nervous system activation, a longitudinal study 
would be necessary. Our results could also be verified from an applicative point of view since an 
intervention aimed at emotional regulation could lead to improvements in both hypertension 
(Mingarelli et al., 2006) and the individual response to pharmacological treatment. 
Despite the promising results, this study has some limitations. Among these, we mention the use of 
two different scales of adherence in the course of data collection, which could have influenced the 
results obtained. Furthermore, failure to control other psychological variables related to 
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alexithymia, such as mood and anxiety, may have weakened the methodological implant. Another 
limitation could be linked to the fact that only the clinical measurement of blood pressure was used, 
and this did not allow to control some aspects of hypertension, such as masked hypertension and 
white coat hypertension (Hanninen et al., 2011). However, further studies may enable investigating 
these aspects by considering blood pressure monitoring for 24 hours.  
One of the most critical limitations of the study is the lack of a specific analysis of drug treatment. 
It would be useful to consider the effect of different drugs on hypertension, and more importantly, 
try to analyse the nature of the relationship between drugs treatment and alexithymia in 
hypertensive individuals. Individuals with uncontrolled hypertension showed higher levels of 
alexithymia compared to normotensive people, but the role of the drugs could not be controlled.  
Controlling dose and type of medications could allow considering the possible modulation effects 
of treatment. To know the specific type and dose of the medications used to treat hypertension 
might let to understand better if the type of drug taken modulates certain emotional aspects in 
hypertensive patients.  
In the present study, we chose to consider the European guidelines (Mancia et al., 2013; Williams et 
al., 2018) on which pharmacological therapy was based. It could be interesting to compare these 
results with other studies that analysed the relationship between hypertension and emotional 
regulation considering the ACC/AHA guidelines (Whelton et al., 2017), which changed the cut-off 
for the classification of hypertension, lowering the risk threshold.  
Moreover, it would be interesting to consider how different severity levels of hypertension (Mancia 
et al., 2013; Williams et al., 2018) influence this relationship.  
A future study could consider anxiety and arousal measures to support the findings from this study 
and the idea that hypertensive individuals could express their emotions through the physiological 
components. For example, it could be useful to consider the Heart Rate Variability measure that 
could be given more information about physiological activation (e.g., Forte et al., 2019). 
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
19 
 
From our point of view, the results of this study could have two possible implications. On the one 
hand, alexithymia could represent a risk factor associated with the increase in blood pressure. On 
the other hand, alexithymia could be a consequence of hypertension. Disentangling these two 
possibilities without longitudinal data is impossible. Therefore, it would be important to analyse this 
relationship in other studies. 
5. Conclusion 
In summary, this study highlighted a relationship between alexithymia and essential hypertension. 
We could hypothesise that hypertensive people are confused about their emotions. They also 
somatise emotions, minimise affective components and express their emotions through the 
physiological components because they cannot consciously process their emotions.  
However, unlike previous studies that evidence a general relationship between alexithymia and 
hypertension, this study has found that this relationship is present to a higher extension in 
hypertensive patients that cannot maintain control of their blood pressure despite following 
pharmacological treatment. Thus, alexithymia would appear to be associated with higher severity of 
hypertension and should be considered a risk factor in the development and maintenance of 
hypertension, even under pharmacologically controlled conditions. 
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Figure 1. Selection of the participants. 
 
Figure 2. Means and SE of (a) the Total Score and (b) the three TAS-20 Subscales scores in the 
three Groups. 
TH: Treated Hypertensive Group; UH: Untreated Hypertensive Group; NH: Normotensive Group; DIF: Difficulty 
Identifying Feelings; DDF: Difficulty Describing Feeling; EOT: External Oriented Thinking. [*Total Score: TH vs NH: 
p< 0.01; TH vs UH: p= 0.05]; [*DIF: TH vs NH: p< 0.002; *EOT: TH vs UH: p< 0.01; TH vs UH: p= 0.06]. 
 
 
Figure 3. Means and SE of (a) the Total Score and (b) the scores of the three TAS-20 Subscales in 
the four Groups. 
NH: Normotensive Group; UH: Untreated Hypertension Group; CH: Controlled Hypertension Group; UCH: 
Uncontrolled Hypertension Group; DIF: Difficulty Identifying Feelings; DDF: Difficulty Describing Feeling; EOT: 
External Oriented Thinking. [*Total Score: UCH vs NH: p< 0.01; UCH vs UH: p<0.04] [*DIF: UCH vs NH: p< 0.01; 
*EOT: UCH vs UH: p< 0.01; UCH vs NH: p< 0.06].  
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Table 1. Frequencies of sociodemographic data of Normotensive and Hypertensive Groups. 
  Hypertensive 
    Antihypertensive medication 
 
 
Normotensive 
(N = 431) 
Total 
Hypertensive 
(N=810) 
Untreated 
Hypertension 
(N= 265) 
Total 
Antihypertensive 
medication 
(N=545) 
Controlled 
Hypertension 
(N= 209) 
Uncontrolled 
Hypertension 
(N = 336) 
 N % N % N % N % N % N % 
Male 158 36.7 376 46.4 121 45.7 255 46.8 97 46.4 158 47 
Education Level*             
Primary School 36 8.4 78 9.6 16 6.0 63 11.6 20 9.6 43 12.8 
Secondary I Grade 
School 
51 11.8 170 21.8 62 23.4 122 22.4 46 22.0 76 22.6 
Secondary II Grade 
School 
214 49.7 415 50.5 136 51.3 260 47.7 105 50.2 155 46.1 
Higher Education 130 31.1 148 18.1 51 19.2 100 18.3 38 18.2 62 18.5 
Marital Status             
Widowed 15 3.5 70 8.6 16 6 54 9.9 20 9.6 34 10.1 
Divorced 33 7.7 73 9 22 8.3 51 9.4 18 8.6 33 9.8 
Single 43 10 71 8.8 27 10.2 44 8.1 19 9.1 25 7.4 
Married 340 78.9 596 73.6 200 75.5 396 72.6 152 72.7 244 72.6 
Working Status*             
Unemployed 13 3.0 17 2.1 9 3.4 8 1.5 2 1 6 1.8 
Employed 296 68.7 346 42.7 153 57.7 193 35.4 77 36.8 116 34.5 
Retired/homemaker 112 26.0 388 47.9 87 32.8 301 55.2 110 52.6 191 56.8 
Lifestyles 
Current Smokers 
 
42 
 
9.7 148 18.3 
 
65 
 
24.5 83 15.2 
 
33 
 
15.8 
 
50 
 
14.9 
Excessive Alcohol 
Consumption** 
1 0.2 15 1.9 8 3.0 7 1.3 1 0.5 6 1.8 
Cardiovascular 
diseases Familiarity 
            
Yes 129 29.9 460 56.8 134 50.6 326 59.8 133 63.6 193 57.4 
No 302 70.1 350 43.2 131 49.4 219 40.2 76 36.4 143 42.6 
TAS-20             
Alexithymic 49 11.4 133 16.4 32 12.1 101 18.5 42 20.1 59 17.6 
Moderately 
Alexithymic 
69 16.0 197 24.4 54 20.4 143 26.2 50 23.9 93 27.7 
Non Alexithymic 313 72.6 480 59.2 179 67.5 301 55 117 56.0 183 54.5 
*Missing Data: Worker [NH= 10 (2.3%); HP= 59 (7.3%)]. ** Excessive Alcohol Consumption >2 drinks and/or wine glasses per 
day. 
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Table 2. Mean and Standard Deviation of demographic, lifestyle and physiological variables, and TAS-20 
scores in normotensive and hypertensive groups. 
 
Normotensive 
(N= 431) 
Hypertensive 
(N= 810) F p 
Age (years) 51.54 (10.17) 60.08 (11.15) 175.09 0.0001 
Education (years) 13.45 (4.26) 12.17 (4.27) 23.92 0.0001 
BMI (Kg/m2) 24.94 (3.74) 26.57 (4.19) 44.21 0.0001 
Systolic BP (mmHg) 118.09 (10.65) 145.81 (20.19) 707.14 0.0001 
Diastolic BP (mmHg) 75.23 (7.75) 90.59 (12.72) 524.31 0.0001 
Heart Rate (beats per min) 72.58 (10.07) 72.84 (12.56) 28.29 0.0001 
Mean Arterial BP (mmHg) 89.52 (7.92) 108.99 (13.31) 776.07 0.0001 
Pharmacological Treatment (numbers) NA 0.85 (0.84) - - 
Smoking Cigarettes (number per die) 1.29 (3.92) 1.75 (5.25) 1.37 0.24 
Drink or Wine (number of glasses per day) 0.16 (0.41) 0.28 (0.64) 6.39 0.01 
TAS-20* (points)     
Difficulties Identifying Feelings 14.47 (6.40) 16.28 (6.54) 5.40* 0.02 
Difficulties Describing Feelings 12.24 (4.27) 13.21 (4.63) 1.06* 0.30 
External Oriented Thinking 18.36 (5.04) 19.52 (5.01) < 1* 0.46 
Total Score 45.08 (12.00) 49.01 (12.10) 3.92* 0.05 
*Adjusted for covariates (BMI; ages; Years of education). 
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Table 3. Mean and Standard Deviation of demographic, lifestyle and physiological variables, and TAS-20 
scores in Normotensive, Untreated and Treated Hypertensive groups. 
 
Normotensive 
(N= 431) 
Untreated 
Hypertensive 
(N= 265) 
Treated 
Hypertensive 
(N= 545) F p 
Age (years) 51.54 (10.17)
a 
55.55 (10.32)
b
 62.29 (10.88) 129.19 0.0001 
Education (years) 13.45 (4.26)
a
 12.48 (4.05) 12.03 (4.37)
 
12.88  0.0001 
BMI (Kg/m2) 24.94 (3.74)
a
 25.75 (3.70)
b
 26.97 (4.36)
 
30.00 0.0001 
Systolic BP (mmHg) 118.09 (10.65)
a
 149.18 (16.81)
b
 144.17 (21.47)
 
364.94 0.0001 
Diastolic BP (mmHg) 75.23 (7.75)
a 
96.48 (10.69)
b
 87.73 (12.64)
 
346.01 0.0001 
Heart Rate (beats per min) 72.58 (10.07)
a
 77.99 (12.12)
b
 70.25 (11.99)
 
21.21 0.0001 
Mean Arterial BP (mmHg) 89.52 (7.92)
a
 114.01 (10.77)
b
 106.54 (13.74)
 
450.24 0.0001 
Pharmacological Treatment (n°) NA NA 1.47 (0.67) - - 
Smoking Cigarettes (n° per die) 1.29 (3.92)
c 
2.73 (6.57)
b
 1.36 (4.35) 7.81 0.001 
Drink or Wine (n° of glasses per 
day) 
0.16 (0.41)
a 
0.32 (0.74) 0.26 (0.59)
 
3.89 0.02 
TAS-20* (points)      
Difficulties Identifying Feelings 14.47 (6.40)
d 
15.57 (6.64) 16.37 (6.47)
 
3.31* 0.04 
Difficulties Describing Feelings 12.24 (4.27) 12.76 (4.53)
 
 13.43 (4.67)
 
 < 1* 0.48 
External Oriented Thinking 18.36 (5.04)
d 
18.48 (4.92)
b 
20.03 (4.97)
 
3.89* 0.02 
Total Score 45.08 (12.00)
d 
46.81 (11.49)
b 
50.10 (12.25)
 
3.88* 0.02 
*Adjusted for covariates (BMI; ages; Years of education). 
 
a 
Normotensive are different from both Untreated and Treated Hypertensive  
b
 Untreated Hypertensive are different from Treated Hypertensive  
c
 Normotensives are different from Untreated Hypertensive  
d
 Normotensives are different from Treated Hypertensive  
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Table 4. Mean and Standard Deviation of demographic, lifestyle and physiological variables, and TAS-20 
scores in Normotensive, Untreated, Controlled and Uncontrolled Hypertensive groups. 
  Hypertensive   
 
Normotensive 
(N= 431) 
Untreated 
(N= 265) 
Controlled 
(N= 209) 
Uncontrolled 
(N= 336) 
F p 
Age (years) 
51.54 
(10.17)a 
55.55 (10.33)b 62.00 (10.82) 62.46 (10.93) 86.16 0 0001 
Education (years) 13.45 (4.26)a 12.57 (3.86) 12.22 (4.00) 12.13 (4.28) 7.88 0.0001 
BMI (Kg/m2) 24.94 (3.74)a 25.76 (3.70)b 26.83 (3.89) 27.05 (4.62) 20.11 0.0001 
Systolic BP (mmHg) 
118.09 
(10.65)a 
149.18 (16.81)b 125.36 (9.63)c 155.86 (18.25) 552.1 0.0001 
Diastolic BP (mmHg) 75.23 (7.75)a 96.48 (10.69)b 79.62 (7.49)c 92.77 (12.58) 349.04 0.0001 
Heart Rate (beats per min) 
72.58 
(10.07)d 
77.99 (12.12)b 67.77 (10.58)c 72.69 (12.80) 18.70 0.0001 
Mean Arterial BP (mmHg) 89.52 (7.92)a 114.01 (10.77)e 94.87 (6.79)e 113.80 (11.83) 588.2 0.0001 
Pharmacological Treatment 
(numbers) 
NA NA 1.53 (0.69)c 1.45 (0.52) 2.34 0.13 
Smoking Cigarettes (number per 
die) 
1.29 (3.92) 2.73 (6.58)f 1.25 (4.33) 1.27 (4.38) 5.20 0.001 
Drink or Wine (number of 
glasses per day) 
0.16 (0.41)a 0.32 (0.74)e 0.19 (0.43)c 0.30 (0.67) 3.97 0.01 
Adherence (z score) NA NA 0.20 (0.74) 0.07 (0.87) 1.74 0.19 
TAS-20* (points)       
Difficulties Identifying Feelings 14.47 (6.40)g 15.57 (6.64) 16.25 (6.54) 16.86 (6.43) 2.62 0.05 
Difficulties Describing Feelings 12.24 (4.27) 12.76 (4.53) 13.35 (4.87) 13.47 (4.54) <1 0.70 
External Oriented Thinking 18.36 (5.04) 18.48 (4.92) 19.94 (4.67) 20.09 (5.15)h 2.30 0.07 
Total Score 45.08 (12.00) 46.81 (11.49) 49.54 (12.90) 50.43 (11.85)h 2.73 0.04 
*Adjusted for covariates (BMI; ages; Years of education).  
a Normotensive are different from Untreated, Controlled and Uncontrolled Hypertensive  
b Untreated Hypertensive are different from Controlled and Uncontrolled Hypertensive  
c Controlled Hypertensive are different from Uncontrolled Hypertensive  
d Normotensives are different from Untreated and Controlled Hypertensive 
e Untreated Hypertensive are different from Controlled Hypertensive 
f Untreated Hypertensive are different from Normotensive, Controlled and Uncontrolled Hypertensive 
g Normotensive are different from Uncontrolled Hypertensive 
h Uncontrolled Hypertensive are different from Normotensive and Untreated Hypertensive. 
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Highlights 
•    Alexithymia appears to be related to Uncontrolled Hypertension 
•    Alexithymia is associated with failure in the therapeutic goals in hypertensive patients. 
•    Alexithymia seems to be associated with higher severity of Hypertension. 
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